124 related articles for article (PubMed ID: 37075565)
1. Quantifying the value of older adult-specific clinical trials: Post-lumpectomy irradiation among older adults with early-stage breast cancer.
Lee W; Carlson JJ; Basu A; Veenstra D
J Geriatr Oncol; 2023 May; 14(4):101487. PubMed ID: 37075565
[TBL] [Abstract][Full Text] [Related]
2. How does cumulative evidence from older adult-specific trials influence clinical practice? A difference-in-differences analysis in early-stage breast cancer.
Lee W; Basu A; Carlson JJ; Veenstra D
Contemp Clin Trials; 2023 May; 128():107135. PubMed ID: 36868347
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness assessment of lumpectomy cavity boost in elderly women with early stage estrogen receptor positive breast cancer receiving adjuvant radiotherapy.
Lester-Coll NH; Rutter CE; Evans SB
Radiother Oncol; 2016 Apr; 119(1):52-6. PubMed ID: 26867968
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer.
Deshmukh AA; Shirvani SM; Lal L; Swint JM; Cantor SB; Smith BD; Likhacheva A
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059428
[TBL] [Abstract][Full Text] [Related]
5. Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
Chu QD; Zhou M; Medeiros KL; Peddi P; Wu XC
Anticancer Res; 2017 Oct; 37(10):5585-5594. PubMed ID: 28982874
[TBL] [Abstract][Full Text] [Related]
6. The Role of Radiation Therapy in Addition to Lumpectomy and Hormone Therapy in Men 70 Years of Age and Older with Early Breast Cancer: A NCDB Analysis.
Bateni SB; Perry LM; Zhao X; Arora M; Daly ME; Stewart SL; Bold RJ; Canter RJ; Sauder CAM
Ann Surg Oncol; 2021 May; 28(5):2463-2471. PubMed ID: 33094375
[TBL] [Abstract][Full Text] [Related]
7. An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial).
Vaidya JS; Wenz F; Bulsara M; Tobias JS; Joseph DJ; Saunders C; Brew-Graves C; Potyka I; Morris S; Vaidya HJ; Williams NR; Baum M
Health Technol Assess; 2016 Sep; 20(73):1-188. PubMed ID: 27689969
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States.
Guzauskas GF; Garbett S; Zhou Z; Spencer SJ; Smith HS; Hao J; Hassen D; Snyder SR; Graves JA; Peterson JF; Williams MS; Veenstra DL
JAMA Netw Open; 2020 Oct; 3(10):e2022874. PubMed ID: 33119106
[TBL] [Abstract][Full Text] [Related]
9. The evolving role of adjuvant radiotherapy for elderly women with early-stage breast cancer.
Rutter CE; Lester-Coll NH; Mancini BR; Corso CD; Park HS; Yeboa DN; Gross CP; Evans SB
Cancer; 2015 Jul; 121(14):2331-40. PubMed ID: 25810128
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
11. Increased Mortality with Repeat Lumpectomy Alone After Ipsilateral Breast Tumor Recurrence.
Su Y; Guo R; Xue J; Chi Y; Chi W; Wang J; Yang B; Wu J
Oncologist; 2019 Sep; 24(9):e818-e827. PubMed ID: 30842240
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. The Use of Hormone Therapy Alone Versus Hormone Therapy and Radiation Therapy for Breast Cancer in Elderly Women: A Population-Based Study.
Nichol AM; Chan EK; Lucas S; Smith SL; Gondara L; Speers C; Tyldesley S
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):829-839. PubMed ID: 28602413
[TBL] [Abstract][Full Text] [Related]
14. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.
Whelan TJ; Lada BM; Laukkanen E; Perera FE; Shelley WE; Levine MN
Cancer Prev Control; 1997 Aug; 1(3):228-40. PubMed ID: 9765748
[TBL] [Abstract][Full Text] [Related]
15. Long-term Impact of CALGB 9343 on Radiation Utilization.
Squeo G; Malpass JK; Meneveau M; Balkrishnan R; Desai RP; Lattimore C; Anderson RT; Showalter SL
J Surg Res; 2020 Dec; 256():577-583. PubMed ID: 32805580
[TBL] [Abstract][Full Text] [Related]
16. Disparities in the Initial Local Treatment of Older Women with Early-Stage Breast Cancer: A Population-Based Study.
LeMasters TJ; Madhavan SS; Sambamoorthi U; Vyas AM
J Womens Health (Larchmt); 2017 Jul; 26(7):735-744. PubMed ID: 28170302
[TBL] [Abstract][Full Text] [Related]
17. Cost comparison of radiation treatment options after lumpectomy for breast cancer.
Greenup RA; Camp MS; Taghian AG; Buckley J; Coopey SB; Gadd M; Hughes K; Specht M; Smith BL
Ann Surg Oncol; 2012 Oct; 19(10):3275-81. PubMed ID: 22851048
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States.
Shah BD; Smith NJ; Feng C; Jeyakumar S; Castaigne JG; Faghmous I; Masouleh BK; Malone DC; Bishop MR
Adv Ther; 2022 Aug; 39(8):3678-3695. PubMed ID: 35727476
[TBL] [Abstract][Full Text] [Related]
19. Partial breast irradiation for early breast cancer.
Lehman M; Hickey BE; Francis DP; See AM
Cochrane Database Syst Rev; 2014 Jun; (6):CD007077. PubMed ID: 24938937
[TBL] [Abstract][Full Text] [Related]
20. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
